Marshall Wace’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.3M Buy
456,996
+185,615
+68% +$1.66M ﹤0.01% 1376
2025
Q4
$2.2M Buy
271,381
+252,281
+1,321% +$2.76M ﹤0.01% 1532
2025
Q3
$271K Sell
19,100
-29,551
-61% -$390K ﹤0.01% 2467
2025
Q2
$635K Buy
48,651
+29,037
+148% +$399K ﹤0.01% 2055
2025
Q1
$292K Sell
19,614
-73,929
-79% -$1.27M ﹤0.01% 2278
2024
Q4
$1.7M Buy
93,543
+82,063
+715% +$1.11M ﹤0.01% 1512
2024
Q3
$154K Buy
+11,480
New +$169K ﹤0.01% 2327
2023
Q2
Sell
-14,500
Closed -$324K 2508
2023
Q1
$324K Buy
+14,500
New +$380K ﹤0.01% 2267
2021
Q2
Sell
-53,045
Closed -$663K 2689
2021
Q1
$663K Sell
53,045
-60,095
-53% -$637K ﹤0.01% 1825
2020
Q4
$1M Buy
113,140
+48,272
+74% +$393K 0.01% 1205
2020
Q3
$421K Buy
64,868
+9,233
+17% +$58.5K ﹤0.01% 1283
2020
Q2
$343K Buy
+55,635
New +$341K ﹤0.01% 1296
2019
Q4
Sell
-42,917
Closed -$442K 1730
2019
Q3
$442K Buy
+42,917
New +$422K ﹤0.01% 1130
2019
Q1
Sell
-5,965
Closed -$44K 1741
2018
Q4
$44K Buy
+5,965
New +$50K ﹤0.01% 1460

Other funds holding CCRN

Marshall Wace's CCRN Position: Q1 2026 in Review

Marshall Wace increased its Cross Country Healthcare (CCRN) stake by 68% in Q1 2026, buying an estimated $1.66M and bringing the position to 456,996 shares worth $4.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1376.

Marshall Wace first reported a position in CCRN in Q4 2018 and has held it in 14 quarters since. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Marshall Wace held 456,996 shares of Cross Country Healthcare worth $4.3M as of Q1 2026.
  • Marshall Wace bought 185,615 Cross Country Healthcare shares in Q1 2026, an estimated $1.66M.
  • Cross Country Healthcare made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1376 holding.
  • Marshall Wace first reported a position in Cross Country Healthcare in Q4 2018 and has held it in 14 quarters since.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.